The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the “major global health challenge” of obesity.
The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the “major global health challenge” of obesity.
Comments are closed.